SCHEMBL25842158

SCHEMBL25842158

C=C(N)Nc1c2c(nc(C3CC3)c1C1CC1)CCC2

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 2/20 0.46
CYP1A2 P05177 1/20 0.35
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
USP2 O75604 1/20 0.35
EEF2K O00418 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ACHE P22303 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TSHR P16473 1/20 0.33
EHMT2 Q96KQ7 1/20 0.32
MAPK1 P28482 1/20 0.31
BPTF Q12830 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25841799 0.86 NLRP3 (0.43) NLRP3CYP1A2GAANPSR1USP2
SCHEMBL25821017 0.86 NLRP3 (0.50) NLRP3CYP1A2GAANPSR1USP2
SCHEMBL25834605 0.77 NLRP3 (0.45) NLRP3CYP1A2GAANPSR1USP2
SCHEMBL21962951 0.72 ACHE (0.52) NLRP3CYP1A2EEF2KKDM4EACHE
SCHEMBL24978435 0.72 NLRP3 (0.44) NLRP3CYP1A2GAANPSR1USP2
SCHEMBL22020362 0.71 GAA (0.43) NLRP3CYP1A2GAANPSR1USP2
SCHEMBL25838016 0.71 GAA (0.43) NLRP3CYP1A2GAANPSR1USP2
SCHEMBL22020067 0.69 KDM4E (0.36) NLRP3CYP1A2EEF2KKDM4EACHE
SCHEMBL21963067 0.68 GAA (0.46) NLRP3CYP1A2GAANPSR1USP2
SCHEMBL22020016 0.67 GAA (0.44) NLRP3CYP1A2GAANPSR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3880666-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2023-06-28 EP disclosed